Stay updated on Cabozantinib vs Paclitaxel in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib vs Paclitaxel in Ovarian Cancer Clinical Trial page.

Latest updates to the Cabozantinib vs Paclitaxel in Ovarian Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRecruitment status now states that enrollment is closed. The update also adds help and navigation sections, refines a label, and updates the revision tag to v3.6.0.SummaryDifference0.2%

- Check16 days agoChange DetectedThe page revision tag was updated from v3.5.4 to v3.5.5, indicating a minor version update to the page. It does not modify study details or visible content.SummaryDifference0.0%

- Check38 days agoChange Detected- The page now shows a new Revision: v3.5.4, replacing the prior v3.5.3, indicating a software version bump. This change reflects an internal update to the site rather than a modification to study information.SummaryDifference0.0%

- Check52 days agoChange DetectedThe page now shows Revision: v3.5.3 instead of Revision: v3.5.2. This reflects a minor update to the page's content or presentation.SummaryDifference0.0%

- Check66 days agoChange DetectedThe site version was updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check95 days agoChange DetectedAdded Revision: v3.5.0. Deleted Revision: v3.4.3.SummaryDifference0.0%

Stay in the know with updates to Cabozantinib vs Paclitaxel in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib vs Paclitaxel in Ovarian Cancer Clinical Trial page.